ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RNAZ TransCode Therapeutics Inc

1.28
-0.05 (-3.76%)
Jun 12 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
TransCode Therapeutics Inc RNAZ NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -3.76% 1.28 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.30 1.22 1.36 1.23 1.33
more quote information »

Recent News

Date Time Source Heading
6/10/202408:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
6/10/202407:00GLOBENasdaq Determines That TransCode Therapeutics Has Regained..
6/07/202416:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
6/07/202416:00EDGAR2Form 8-K - Current report
5/29/202409:15GLOBETransCode Therapeutics Reports Positive Data from..
5/20/202416:00EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
5/15/202417:13EDGAR2Form 8-K - Current report
5/13/202417:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
5/13/202408:30GLOBETransCode Therapeutics Open Letter to Shareholders
5/10/202416:50EDGAR2Form PRE 14A - Other preliminary proxy statements
5/10/202416:45EDGAR2Form 8-K - Current report
4/15/202409:00GLOBETransCode Therapeutics Announces FDA Clearance To Initiate..
4/03/202409:10GLOBETransCode Therapeutics Reports 2023 Results; Provides..
3/28/202408:30GLOBETransCode Therapeutics Announces Appointment of Daniel..
3/11/202409:00GLOBETransCode Therapeutics and Akribion Genomics Report Progress..
3/06/202416:15GLOBETransCode Therapeutics To Present At 2024 RNA Leaders Europe..
2/20/202408:00GLOBETransCode Therapeutics Reports Publication of United States..
2/15/202416:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202420:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202416:33EDGAR2Form 8-K - Current report
1/31/202416:05GLOBENasdaq Determines TransCode Therapeutics Compliance with..
1/29/202408:30GLOBETransCode Therapeutics and Debiopharm Announce Collaboration..
1/22/202416:45EDGAR2Form 8-K - Current report
1/22/202416:45GLOBETransCode Therapeutics Announces Closing of $7.25 Million..
1/19/202421:57EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
1/19/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
1/18/202413:27GLOBETransCode Therapeutics Announces Pricing of $7.25 Million..
1/18/202410:39EDGAR2Form S-1/A - General form for registration of securities..
1/17/202407:06EDGAR2Form S-1/A - General form for registration of securities..
1/16/202416:01EDGAR2Form 8-K - Current report
1/12/202416:05GLOBETransCode Therapeutics Reports Further Restructuring to..
1/11/202408:22EDGAR2Form S-1 - General form for registration of securities under..
1/11/202408:00GLOBETransCode Therapeutics Announces 1-for-40 Reverse Stock..
1/08/202416:01EDGAR2Form 8-K - Current report
1/04/202412:41EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/04/202408:05GLOBETransCode Therapeutics Publishes Open Letter Outlining..
12/18/202316:28EDGAR2Form DEF 14A - Other definitive proxy statements
12/12/202308:30GLOBETransCode Therapeutics Reports Positive Pre-Clinical Results..
12/08/202316:57EDGAR2Form PRE 14A - Other preliminary proxy statements
12/08/202316:56EDGAR2Form 8-K - Current report
12/07/202316:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/05/202309:00GLOBETransCode Therapeutics To Present Phase 0 Data at 2023 San..
12/04/202317:07EDGAR2Form 8-K - Current report
12/04/202316:10GLOBETransCode Therapeutics Announces Closing of $1.2 Million..
12/01/202317:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/30/202314:53GLOBETransCode Therapeutics Announces $1.2 Million Registered..
11/14/202316:40EDGAR2Form 8-K - Current report
11/14/202316:30GLOBETransCode Therapeutics Reports Third Quarter 2023 Results;..
11/09/202316:13EDGAR2Form 8-K - Current report
10/31/202322:20APSBiotech Shares Bid Up Following Public Offering Cancellation

Your Recent History

Delayed Upgrade Clock